Capital expenditure decreased 100.0%
Capital expenditure changed -100.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure changed -100.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Inventory changed +36.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating margin changed +1642 basis points from the comparable as-filed period.
Gross margin changed +820 basis points from the comparable as-filed period.
Stock-based compensation changed +102.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
SBC / revenue changed +924 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Revenue changed +23.2% from the comparable as-filed period.
Gross profit changed +38.6% from the comparable as-filed period.
Operating income changed -15.4% from the comparable as-filed period.
Capex / revenue changed -752 basis points from the comparable as-filed period.
Free-cash-flow margin changed -3043 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Inventory / revenue changed +1208 basis points from the comparable as-filed period.
Operating cash-flow margin changed -3795 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.